KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank58
3Y CAGR-19.8%
5Y CAGR+2.6%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
-19.8%/yr
vs +61.4%/yr prior
5Y CAGR
+2.6%/yr
Recent deceleration
Acceleration
-81.3pp
Decelerating
Percentile
P58
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $95.39M | -53.8% |
| 2024 | $206.58M | +28.3% |
| 2023 | $161.03M | -13.0% |
| 2022 | $185.09M | -28.0% |
| 2021 | $257.19M | +207.1% |
| 2020 | $83.75M | -13.4% |
| 2019 | $96.74M | +255.0% |
| 2018 | $27.25M | -13.0% |
| 2017 | $31.33M | +45.7% |
| 2016 | $21.50M | - |